Back to Trades
Grant4
Organon & Co.
OGN
Total Value
$136.5K
Company Information
- Company Name
- Organon & Co.
- Ticker Symbol
- OGN
- CIK
- 0001821825
Insider Information
- Name
- WALSH MATTHEW M
- Role
- Chief Financial Officer
- Location
- JERSEY CITY, NJ
Officer
Filing Details
- Filing Date
- Mar 3, 2026
- Transaction Date
- Feb 27, 2026
- Accession Number
- 0001628280-26-014228
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | 42,599 | — | Grant/Award | — |
| Feb 27, 2026 | Common Stock | 14,887 | $7.17 | Tax Withholding | $106.7K |
| Feb 27, 2026 | Common Stock | 12,020 | — | Grant/Award | — |
| Feb 27, 2026 | Common Stock | 4,117 | $7.23 | Tax Withholding | $29.8K |
Footnotes
- (F1)Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 11, 2023 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
- (F2)Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.
- (F3)Includes the addition of 652 shares of Common Stock acquired from dividend equivalents net of withholding tax not previously required to be reported.